Earum Pharmaceuticals Rights Issue 2023 Latest News Today

1. Meitheal Pharmaceuticals gains exclusive U.S. commercial rights to Humira biosimilar

   June 28, 2024 3:30:00 AM

   Meitheal, a biopharmaceutical company focused on developing and commercializing generic injectables, fertility, biologic and branded products, has gained exclusive U.S. commercial rights to ...

   Published by : Drug Store News

2. Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade

   June 26, 2024 5:51:00 PM

   Teva Pharmaceuticals has settled years of tax litigation with the Israel Tax Authority for $750 million, which the company will pay in installments starting in 2024 to 2029.

   Published by : BioSpace

3. Taseko Issues 2023 Sustainability Report

   June 25, 2024 8:09:00 PM

   The report focuses on the Company's operational and sustainability achievements at the Gibraltar Mine in 2023, and also highlights ... and our continued focus on the issues and opportunities ...

   Published by : Yahoo Finance

4. Earum Pharmaceuticals (EARUM PHARMACEU.) Share Price

   June 18, 2024 3:30:00 AM

   you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in ...

   Published by : India Infoline

5. Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout

   July 2, 2024 8:26:00 PM

   Syros Pharmaceuticals focuses on myeloid cancer therapies with promising pipeline candidate tamibarotene, facing financial challenges. Explore more details here.

   Published by : Seeking Alpha

6. SEPC�s rights issue to open on July 5, offering 6 shares for every 55 held

   June 24, 2024 7:08:00 PM

   SEPC Limited is set to launch a rights issue with a record date tomorrow, offering shareholders an opportunity to purchase additional shares at a discounted price. The issue opens on July 5 and ...

   Published by : Business Line

7. SITE Centers Issues 2023 Corporate Sustainability Report

   June 27, 2024 4:55:00 PM

   We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

   Published by : Morningstar

8. Rights issue: Byjus moves HC against NCLT order

   June 24, 2024 9:42:00 AM

   Byju's challenges NCLT order in Karnataka High Court. NCLT restricts second tranche of $200-million rights issue, citing cash-strapped situation. Investors like Prosus oppose rights issue.

   Published by : Indiatimes

9. LGBT Rights

   June 27, 2024 3:31:00 AM

   and transgender peoples' rights, and with activists representing a multiplicity of identities and issues. We document and expose abuses based on sexual orientation and gender identity worldwide ...

   Published by : Human Rights Watch

10. Celebrity Social Issues

    June 20, 2024 8:02:00 PM

    Kamala Harris Says There's 'No Denying' Racism in America After Nikki Haley Claimed U.S. Has 'Never Been Racist' Miss America Has Never Been an Active-Duty Air Force Officer � Until Now: 'I Wasn ...

    Published by : People

Read Earum Pharmaceuticals Rights Issue 2023 current news. Find Earum Pharmaceuticals Rights Issue 2023 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Earum Pharmaceuticals Limited Rights Issue grey market premium and Earum Pharmaceuticals Rights Issue 2023 expected listing price.

Read more about Earum Pharmaceuticals Rights Issue 2023

• Earum Pharmaceuticals Rights Issue 2023 Detail
• Earum Pharmaceuticals Rights Issue 2023 Review
• Earum Pharmaceuticals Rights Issue 2023 FAQ's
• Earum Pharmaceuticals Rights Issue 2023 Live News
• Earum Pharmaceuticals Rights Issue 2023 Rights Issue Calendar Events